Nicola Vianelli

St Orsola Malpighi University Hospital
Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Real-world experiences with subcutaneous therapy in adults with primary immune thrombocytopenia: A dual cross-sectional survey study of patients and clinicians in Italy.

Real-world experiences with subcutaneous therapy in adults with primary immune thrombocytopenia: A dual cross-sectional survey study of patients and clinicians in Italy.

Journal: Therapeutic advances in hematology

Published: December 24, 2025

Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia.

Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia.

Journal: Blood advances

Published: June 27, 2025

Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study.

Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study.

Journal: British journal of haematology

Published: March 31, 2025

Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study.

Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study.

Journal: Journal of clinical medicine

Published: November 07, 2024

Early Use of Thrombopietin Receptor Agonists (Tpo-Ras) in Clinical Practice: Results from an Italian Survey on Behalf of the Gimema Working Group Anemia and Thrombocytopenia.

Early Use of Thrombopietin Receptor Agonists (Tpo-Ras) in Clinical Practice: Results from an Italian Survey on Behalf of the Gimema Working Group Anemia and Thrombocytopenia.

Journal: Mediterranean journal of hematology and infectious diseases

Published: September 19, 2024

Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study.

Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study.

Journal: Journal of clinical medicine

Published: August 24, 2024

Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study.

Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study.

Journal: Cancer

Published: April 19, 2024

Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.

Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.

Journal: American journal of hematology

Published: April 11, 2024

Real-life use of ropeg-interferon α2b in polycythemia vera: patient selection and clinical outcomes.

Real-life use of ropeg-interferon α2b in polycythemia vera: patient selection and clinical outcomes.

Journal: Annals of hematology

Published: March 20, 2024

Liver and spleen shear-wave elastography in the diagnosis and severity staging of myeloproliferative diseases and myelofibrosis.

Liver and spleen shear-wave elastography in the diagnosis and severity staging of myeloproliferative diseases and myelofibrosis.

Journal: Journal of ultrasound

Published: February 28, 2024

Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.

Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.

Journal: NEJM evidence

Published: February 06, 2024

Diagnosis and management of Evans syndrome in adults: first consensus recommendations.

Diagnosis and management of Evans syndrome in adults: first consensus recommendations.

Journal: The Lancet. Haematology

Published: December 21, 2023

Showing 1-12 of 114

Last Updated: 09/26/2026